Fibromyalgia Trial, Recruiting NCT07585045 Sponsor: Shaikh Zayed Hospital, Lahore Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07585045
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with fibromyalgia (a condition causing widespread pain) based on specific 2016 medical guidelines.
  • You are between 18 and 65 years old.
  • You have tried standard fibromyalgia medications (such as amitriptyline, duloxetine, or pregabalin) for at least 8 weeks without enough relief.
  • You are willing to give your written agreement (consent) to take part in the study.

Who may not be able to join:

  • You have kidney problems or reduced kidney function.
  • You are currently pregnant or breastfeeding.
  • You are already taking magnesium or other mineral supplements.
  • You have been diagnosed with inflammatory arthritis (such as rheumatoid arthritis) or another long-term chronic pain condition.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Masooma Hashmat, FCPS, Shaikh Zayed Hospital, Lahore

Phone: +923353053304

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shaikh Zayed Hospital, Lahore
Registry
ClinicalTrials.gov
Start date
16 April 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Revised Fibromyalgia Impact Questionnaire (FIQR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov